Drug Type Small molecule drug |
Synonyms BMT-133218 |
Target |
Action modulators |
Mechanism mGluR2 modulators(Metabotropic glutamate receptor 2 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizophrenia | Preclinical | United States | 01 Jan 2017 |